163 related articles for article (PubMed ID: 19122308)
1. Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea.
Toyama T; Seki R; Kasama S; Isobe N; Sakurai S; Adachi H; Hoshizaki H; Oshima S; Taniguchi K
Circ J; 2009 Feb; 73(2):299-304. PubMed ID: 19122308
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea.
Shigemitsu M; Nishio K; Kusuyama T; Itoh S; Konno N; Katagiri T
Int J Cardiol; 2007 Feb; 115(3):354-60. PubMed ID: 16806535
[TBL] [Abstract][Full Text] [Related]
3. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.
Nakao YM; Ueshima K; Yasuno S; Sasayama S
Heart Vessels; 2016 Feb; 31(2):165-72. PubMed ID: 25348726
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and cost-benefit analysis of nocturnal home oxygen therapy in patients with central sleep apnea caused by chronic heart failure.
Seino Y; Imai H; Nakamoto T; Araki Y; Sasayama S;
Circ J; 2007 Nov; 71(11):1738-43. PubMed ID: 17965494
[TBL] [Abstract][Full Text] [Related]
5. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.
Toyama T; Hoshizaki H; Kasama S; Miyaishi Y; Kan H; Yamashita E; Kawaguti R; Adachi H; Ohsima S
J Nucl Cardiol; 2017 Dec; 24(6):1926-1937. PubMed ID: 27387522
[TBL] [Abstract][Full Text] [Related]
6. Assessment of central chemosensitivity and cardiac sympathetic nerve activity using I-123 MIBG imaging in central sleep apnea syndrome in patients with dilated cardiomyopathy.
Meguro K; Toyama T; Adachi H; Ohshima S; Taniguchi K; Nagai R
Ann Nucl Med; 2007 Jan; 21(1):73-8. PubMed ID: 17373339
[TBL] [Abstract][Full Text] [Related]
7. Washout rate of cardiac iodine-123 metaiodobenzylguanidine is high in chronic heart failure patients with central sleep apnea.
Tamura A; Ando S; Goto Y; Kawano Y; Shinozaki K; Kotoku M; Kadota J
J Card Fail; 2010 Sep; 16(9):728-33. PubMed ID: 20797596
[TBL] [Abstract][Full Text] [Related]
8. The effect of successful heart transplant treatment of heart failure on central sleep apnea.
Mansfield DR; Solin P; Roebuck T; Bergin P; Kaye DM; Naughton MT
Chest; 2003 Nov; 124(5):1675-81. PubMed ID: 14605034
[TBL] [Abstract][Full Text] [Related]
9. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration.
Sasayama S; Izumi T; Seino Y; Ueshima K; Asanoi H;
Circ J; 2006 Jan; 70(1):1-7. PubMed ID: 16377916
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea.
Arzt M; Harth M; Luchner A; Muders F; Holmer SR; Blumberg FC; Riegger GA; Pfeifer M
Circulation; 2003 Apr; 107(15):1998-2003. PubMed ID: 12695297
[TBL] [Abstract][Full Text] [Related]
11. Adaptive servo-ventilation to treat central sleep apnea in heart failure with reduced ejection fraction: the Bad Oeynhausen prospective ASV registry.
Oldenburg O; Wellmann B; Bitter T; Fox H; Buchholz A; Freiwald E; Horstkotte D; Wegscheider K
Clin Res Cardiol; 2018 Aug; 107(8):719-728. PubMed ID: 29654439
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure.
Arzt M; Schulz M; Wensel R; Montalvàn S; Blumberg FC; Riegger GA; Pfeifer M
Chest; 2005 Mar; 127(3):794-802. PubMed ID: 15764759
[TBL] [Abstract][Full Text] [Related]
13. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity in patients with heart failure.
Koyama T; Watanabe H; Tamura Y; Oguma Y; Kosaka T; Ito H
Eur J Heart Fail; 2013 Aug; 15(8):902-9. PubMed ID: 23504594
[TBL] [Abstract][Full Text] [Related]
14. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).
Arzt M; Floras JS; Logan AG; Kimoff RJ; Series F; Morrison D; Ferguson K; Belenkie I; Pfeifer M; Fleetham J; Hanly P; Smilovitch M; Ryan C; Tomlinson G; Bradley TD;
Circulation; 2007 Jun; 115(25):3173-80. PubMed ID: 17562959
[TBL] [Abstract][Full Text] [Related]
15. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study.
Egea CJ; Aizpuru F; Pinto JA; Ayuela JM; Ballester E; Zamarrón C; Sojo A; Montserrat JM; Barbe F; Alonso-Gomez AM; Rubio R; Lobo JL; Duran-Cantolla J; Zorrilla V; Nuñez R; Cortés J; Jiménez A; Cifrián J; Ortega M; Carpizo R; Sánchez A; Terán J; Iglesias L; Fernández C; Alonso ML; Cordero J; Roig E; Pérez F; Muxi A; Gude F; Amaro A; Calvo U; Masa JF; Utrabo I; Porras Y; Lanchas I; Sánchez E;
Sleep Med; 2008 Aug; 9(6):660-6. PubMed ID: 17904420
[TBL] [Abstract][Full Text] [Related]
16. Six-month aerobic exercise training ameliorates central sleep apnea in patients with chronic heart failure.
Yamamoto U; Mohri M; Shimada K; Origuchi H; Miyata K; Ito K; Abe K; Yamamoto H
J Card Fail; 2007 Dec; 13(10):825-9. PubMed ID: 18068615
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Am Coll Cardiol; 2005 Mar; 45(5):661-7. PubMed ID: 15734608
[TBL] [Abstract][Full Text] [Related]
18. End-Tidal CO2 Tension Is Predictive of Effective Nocturnal Oxygen Therapy in Patients with Chronic Heart Failure and Central Sleep Apnea.
Sugimura K; Shinozaki T; Fukui S; Ogawa H; Shimokawa H
Tohoku J Exp Med; 2016 May; 239(1):39-45. PubMed ID: 27169493
[TBL] [Abstract][Full Text] [Related]
19. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity.
Mansfield D; Kaye DM; Brunner La Rocca H; Solin P; Esler MD; Naughton MT
Circulation; 2003 Mar; 107(10):1396-400. PubMed ID: 12642360
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction.
Abe T; Yokota T; Fukushima A; Kakutani N; Katayama T; Shirakawa R; Maekawa S; Nambu H; Obata Y; Yamanashi K; Nakano I; Takada S; Yokota I; Okita K; Kinugawa S; Anzai T
Cardiovasc Diabetol; 2020 Sep; 19(1):142. PubMed ID: 32950064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
